Obesity atffects around 13% of the
world's adult population1. Despite being linked to other
serious diseases, including heart disease, type 2 diabetes and some
forms of cancer2, obesity is not always seen as a serious
chronic disease and treatment options are limited. People living with
obesity may also experience stigmatisation because of their weight.
This weight bias may be encountered in the workplace, at school, and
even in the doctor’s office, which could lead to additional physical
and mental health problems
Today, Novo Nordisk is working to change the way people living with obesity are viewed, treated and cared for.
Obesity is complex. Its main cause is an imbalance between energy
consumed as food, and the way the body uses this energy – but this is
only part of the story.
The development of obesity is influenced by a combination of factors both inside and outside the body, including genetics, changes in a person’s metabolism, lifestyle and even how and where a person lives.
Obesity is a serious chronic disease – but it can be treated. And
even small reductions in weight can reduce the risk of additional
complications and improve overall wellbeing.
Depending on individual needs, obesity treatments may include counselling, anti-obesity medications or surgery – in addition to diet and exercise
Living with obesity means facing challenges on many levels. From
finding clothes that look good, to using public transport, to living
with furniture that wasn't designed with the larger customer in mind.
But perhaps the most difficult challenge of all is the prejudice that
people with obesity experience on a daily basis.
Ill-informed attitudes about weight often lead to stigmatisation from employers, friends and family, and even healthcare professionals. This can lead to discrimination and significantly impact an individual's income, educational opportunities, health care quality, emotional health and ability to manage obesity.
Did you know that the human body
naturally resists weight loss3? This is why maintaining
weight loss for more than one year is so challenging, and why diet and
exercise alone are not always enough.
Explore the science behind obesity
Despite the fact that there is now a better understanding of the science behind obesity, medical treatment options remain limited. At Novo Nordisk, our scientists are working to develop new medicines that target the unmet needs of people living with this serious chronic disease.
Volunteer to take part in a Novo Nordisk clinical trial, and you’ll be helping our researchers discover more about new treatments that could one day benefit millions of people worldwide. You’ll also learn about managing your own weight and health.
1World Health Organization. Obesity and Overweight. Fact
sheet No 311. Updated October 2017
2Michele M Yuen, et al. T-P-3166: A systematic review and evaluation of current evidence reveals 236 obesity-associated disorders (ObAD).
3“Obesity.” Rethink Obesity, Novo Nordisk, 2017, global.rethinkobesity.com/. Accessed 1 August 2017